Katja Sockel

3.2k total citations
51 papers, 526 citations indexed

About

Katja Sockel is a scholar working on Hematology, Genetics and Emergency Medicine. According to data from OpenAlex, Katja Sockel has authored 51 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 20 papers in Genetics and 9 papers in Emergency Medicine. Recurrent topics in Katja Sockel's work include Acute Myeloid Leukemia Research (32 papers), Hematopoietic Stem Cell Transplantation (15 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers). Katja Sockel is often cited by papers focused on Acute Myeloid Leukemia Research (32 papers), Hematopoietic Stem Cell Transplantation (15 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers). Katja Sockel collaborates with scholars based in Germany, United Kingdom and France. Katja Sockel's co-authors include Martin Bornhäuser, Uwe Platzbecker, Jan Moritz Middeke, Michael Krämer, Johannes Schetelig, Christoph Röllig, Malte von Bonin, Christian Thiede, Friedrich Stölzel and Frank Kroschinsky and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Katja Sockel

47 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katja Sockel Germany	12	301	196	87	78	77	51	526
Chien‐Ting Lin Taiwan	16	353 1.2×	195 1.0×	300 3.4×	26 0.3×	98 1.3×	33	739
Heinz Diem Germany	12	151 0.5×	217 1.1×	66 0.8×	25 0.3×	108 1.4×	26	550
Marion Eveillard France	11	257 0.9×	78 0.4×	178 2.0×	18 0.2×	143 1.9×	61	451
Leland Metheny United States	13	228 0.8×	107 0.5×	120 1.4×	15 0.2×	170 2.2×	78	442
Chi‐Cheng Li Taiwan	13	137 0.5×	49 0.3×	203 2.3×	31 0.4×	216 2.8×	97	698
Jorge G. Rossi Argentina	13	249 0.8×	67 0.3×	128 1.5×	14 0.2×	98 1.3×	31	547
Daniel Royston United Kingdom	11	125 0.4×	96 0.5×	248 2.9×	35 0.4×	334 4.3×	33	884
Álvaro Gomariz Switzerland	9	276 0.9×	126 0.6×	149 1.7×	8 0.1×	91 1.2×	14	564
Junru Liu China	14	215 0.7×	54 0.3×	227 2.6×	13 0.2×	163 2.1×	79	555
Yoo‐Jin Kim South Korea	16	364 1.2×	127 0.6×	98 1.1×	12 0.2×	151 2.0×	49	617

Countries citing papers authored by Katja Sockel

Since Specialization

Citations

This map shows the geographic impact of Katja Sockel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Sockel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Sockel more than expected).

Fields of papers citing papers by Katja Sockel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Sockel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Sockel. The network helps show where Katja Sockel may publish in the future.

Co-authorship network of co-authors of Katja Sockel

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Sockel. A scholar is included among the top collaborators of Katja Sockel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Sockel. Katja Sockel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eckardt, Jan‐Niklas, Susann Winter, Katja Sockel, et al.. (2025). Image-based explainable artificial intelligence accurately identifies myelodysplastic neoplasms beyond conventional signs of dysplasia. npj Precision Oncology. 10(1). 26–26.

Eckardt, Jan‐Niklas, Susann Winter, Christian Thiede, et al.. (2025). Synthetic bone marrow images augment real samples in developing acute myeloid leukemia microscopy classification models. npj Digital Medicine. 8(1). 173–173. 3 indexed citations

Ganster, Christina, Katayoon Shirneshan, Elżbieta Brzuszkiewicz, et al.. (2024). Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real‐world cohort of patients with lower‐risk MDS. HemaSphere. 8(9). e70014–e70014. 1 indexed citations

Sockel, Katja, Katharina S. Götze, Christina Ganster, et al.. (2024). VEXAS syndrome: complete molecular remission after hypomethylating therapy. Annals of Hematology. 103(3). 993–997. 18 indexed citations

Oelschlaegel, Uta, Susann Winter, Katja Sockel, et al.. (2024). MDS-PB13 Score - Blood based detection of aberrancies by flow cytometry in patients with suspected and confirmed Myelodysplastic Neoplasms. Leukemia. 38(2). 446–450. 1 indexed citations

Rampotas, Alexandros, Katja Sockel, Fotios Panitsas, et al.. (2023). Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter Study. Transplantation and Cellular Therapy. 29(11). 687.e1–687.e7. 2 indexed citations

Zimmermann, Ralf, Mirko Nitschke, Uwe Freudenberg, et al.. (2023). Discriminant Principal Component Analysis of ToF‐SIMS Spectra for Deciphering Compositional Differences of MSC‐Secreted Extracellular Matrices. Small Methods. 7(6). e2201157–e2201157. 8 indexed citations

Mascarenhas, John, Claire Harrison, Jean‐Jacques Kiladjian, et al.. (2023). PB2225: A RANDOMIZED OPEN-LABEL, PHASE 3 STUDY OF IMETELSTAT VS BEST AVAILABLE THERAPY IN INTERMEDIATE-2 OR HIGH-RISK MYELOFIBROSIS RELAPSED/REFRACTORY TO JAK INHIBITOR (IMPACTMF). HemaSphere. 7(S3). e99899f4–e99899f4. 1 indexed citations

Sockel, Katja, Friedrich Stölzel, Christoph Röllig, et al.. (2022). Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse. SHILAP Revista de lepidopterología. 3 indexed citations

10.

Sockel, Katja, et al.. (2022). Established and Emerging Treatments of Skin GvHD. Frontiers in Immunology. 13. 838494–838494. 10 indexed citations

11.

Eckardt, Jan‐Niklas, Michael Krämer, Katja Sockel, et al.. (2022). Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears. BMC Cancer. 22(1). 201–201. 41 indexed citations

12.

Stasik, Sebastian, Michael Krämer, Jan Moritz Middeke, et al.. (2022). Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML. Blood Advances. 6(11). 3294–3303. 16 indexed citations

13.

Vučinić, Vladan, Leo Ruhnke, Katja Sockel, et al.. (2021). The diagnostic red blood cell distribution width as a prognostic factor in acute myeloid leukemia. Blood Advances. 5(24). 5584–5587. 10 indexed citations

14.

Eckardt, Jan‐Niklas, Jan Moritz Middeke, Michael Krämer, et al.. (2021). Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears. Leukemia. 36(1). 111–118. 60 indexed citations

15.

Stölzel, Friedrich, Steffen Löck, Stefani Parmentier, et al.. (2019). The prevalence of extramedullary acute myeloid leukemia detected by ¹⁸FDG-PET/CT: final results from the prospective PETAML trial. Haematologica. 105(6). 1552–1558. 34 indexed citations

16.

Middeke, Jan Moritz, Friedrich Stölzel, Martin Wermke, et al.. (2018). Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(9). 1947–1951. 3 indexed citations

17.

Herold, Sylvia, Katja Sockel, Cyrus Sayehli, et al.. (2017). Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AML. Leukemia. 31(10). 2247–2251. 11 indexed citations

18.

Neukirchen, Judith, et al.. (2013). Real life experience with alemtuzumab treatment of patients with lower-risk MDS and a hypocellular bone marrow. Annals of Hematology. 93(1). 65–69. 7 indexed citations

19.

Wermke, Martin, Anne Schmidt, Jan Moritz Middeke, et al.. (2012). MRI-Based Liver Iron Content Predicts for Nonrelapse Mortality in MDS and AML Patients Undergoing Allogeneic Stem Cell Transplantation. Clinical Cancer Research. 18(23). 6460–6468. 57 indexed citations

20.

Sockel, Katja, Gerhard Ehninger, Lorenz C. Hofbauer, & Uwe Platzbecker. (2011). Optimizing management of myelodysplastic syndromes post-allogeneic transplantation. Expert Review of Hematology. 4(6). 669–680. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact